8-K current report · filed Sep 21, 2026

Axon Enterprise (AXON) 8-K Current Report: September 21, 2026

Item 1.01Item 7.01Item EX-99.1Item 2.03AXON overview

Short answer

Axon Enterprise (AXON) filed an 8-K current report with the SEC on September 21, 2026 reporting Item 1.01 (Entry into a Material Definitive Agreement), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1), Item 2.03 (Creation of a Direct Financial Obligation). $1.15B of 0% convertible notes due September 15, 2031, eliminating cash interest expense through maturity.

Axon Enterprise 8-K event analysis

AI summary of each reported item and its exhibits

Item 1.01 · Entry into a Material Definitive Agreement

  • $1.15B of 0% convertible notes due September 15, 2031, eliminating cash interest expense through maturity
  • Initial conversion price $652.06, a 47.5% premium to the September 15 stock price of $442.08
  • Approximately $114.9M capped-call cost, designed to reduce conversion dilution up to a $1,049.94 share-price cap
  • Net proceeds for growth investment, acquisitions, product development and general corporate purposes
  • Unsecured debt adds refinancing and potential equity-settlement obligations, with no financial or operating covenants

Item 2.03 · Creation of a Direct Financial Obligation

  • New direct financial obligations tied to the Notes, Indenture, and amended Credit Agreement
  • Item 1.01 contains the governing terms, including borrowing amounts, maturity, interest, and covenants
  • Investors should assess added leverage, refinancing exposure, and restrictions under the amended credit facilities

Item 7.01 · Regulation FD Disclosure

  • AXON announced pricing of its Notes Offering on September 15, 2026
  • Debt pricing establishes financing terms and may affect future interest expense and leverage
  • Exhibit 99.1 contains the offering’s specific pricing and transaction details

Item EX-99.1 · Exhibit EX-99.1

  • $1.0B 0% convertible notes due September 15, 2031, providing non-cash-interest financing
  • Approximately $986.0M net proceeds, or $1,134.3M with full over-allotment exercise
  • $99.9M allocated to capped calls, reducing potential conversion dilution up to a $1,049.94 cap price
  • Initial conversion price $652.06 versus $442.08 share price, implying conversion only after substantial appreciation
  • Remaining proceeds support growth, acquisitions, investments, and general corporate purposes

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Axon Enterprise 8-K filings

Get the next AXON 8-K as it lands

Follow AXON for push alerts, or ask the research agent what this filing means.